本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Redhill Biopharma Ltd

1.98
+0.06623.46%
盘后1.990.0100+0.51%18:45 EDT
成交量:4.02万
成交额:7.84万
市值:346.90万
市盈率:-0.30
高:2.03
开:1.89
低:1.85
收:1.91
数据加载中...
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]